In legal terms, are cryptocurrencies considered securities, commodities, or something nobody can define? For many years, the answer to that question was ambiguous. But, on March 17, the Securities and Exchange Commission (SEC) and Commodity Futures Trading Commission (CFTC) published a ruling that officially classified 16 major cryptocurrencies, including Ethereum (CRYPTO: ETH) and Solana (CRYPTO:...
In legal terms, are cryptocurrencies considered securities, commodities, or something nobody can define? For many years, the answer to that question was ambiguous. But, on March 17, the Securities and Exchange Commission (SEC) and Commodity Futures Trading Commission (CFTC) published a ruling that officially classified 16 major cryptocurrencies, including Ethereum (CRYPTO: ETH) and Solana (CRYPTO: SOL) . Both coins are now "digital commodities," which means they fall under the CFTC's lighter-touch oversight rather than the SEC's onerous securities framework. And the new regulatory guidance is a huge catalyst for both, suggesting higher prices ahead, so let's investigate whether they're worth buying with $1,000 right now. Image source: Getty Images. Continue reading
US Offers Up To $3 Million Bounty For Information On Finances Of Haitian Gangs Authored by Kimberly Hayek via The Epoch Times (emphasis ours), The U.S. government on March 25 announced a bounty of up to $3 million for information on the finances of Haiti’s Viv Ansanm and Gran Grif gangs. Armed police ride in the back of a truck after the streets of the Haitian capital, Port-au-Prince, were desert...
US Offers Up To $3 Million Bounty For Information On Finances Of Haitian Gangs Authored by Kimberly Hayek via The Epoch Times (emphasis ours), The U.S. government on March 25 announced a bounty of up to $3 million for information on the finances of Haiti’s Viv Ansanm and Gran Grif gangs. Armed police ride in the back of a truck after the streets of the Haitian capital, Port-au-Prince, were deserted following a call for a general strike launched by several professional associations and companies to denounce insecurity in Port-au-Prince, on Oct. 18, 2021. Richard Pierrin/AFP via Getty Images The United States designated both groups, which bring together hundreds of gangs in the capital Port-au-Prince, the agricultural Artibonite region, and central Haiti, as terrorist organizations in May 2025. The two gangs are a “primary source of instability and violence in Haiti” and are a “direct threat to U.S. national security interests in our region,” Secretary of State Marco Rubio said at the time, adding that they are “committed to overthrowing the government of Haiti.” Gangs have grown in power since the assassination of President Jovenel Moïse in 2021. They are estimated to control about 90 percent of the capital, Port-au-Prince, according to a 2025 U.N. security briefing, and have expanded their activities into the countryside, including looting, kidnapping, sexual assaults, and rape. Haiti has not had a president since the assassination. The U.S. Embassy in Haiti said in a March 25 statement that Viv Ansanm members are “responsible for an ongoing campaign of violence, including attacks against the government of Haiti, prison systems, police stations, hospitals, and the nation’s main airport in Port-au-Prince,” while Viv Ansanm is “directly involved in the mass murder and collective rape of Haitian civilians, including violence against American citizens in Haiti.” Haitian security forces, with the support of a partially deployed U.N.-backed force and a U.S. private mil...
Arthur Tzianabos, the chair of Stoke Therapeutics (NASDAQ:STOK) , disclosed the direct sale of 4,355 shares of Common Stock for a transaction value of approximately $174,000 on March 10, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($40.00); post-transaction value based on March 10, 2026 market close price. Stoke Therapeutics is an ...
Arthur Tzianabos, the chair of Stoke Therapeutics (NASDAQ:STOK) , disclosed the direct sale of 4,355 shares of Common Stock for a transaction value of approximately $174,000 on March 10, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($40.00); post-transaction value based on March 10, 2026 market close price. Stoke Therapeutics is an early-stage biotechnology company leveraging its proprietary platform to design RNA-based therapeutics for severe genetic diseases. The company’s strategy centers on advancing its pipeline of ASO candidates while forming partnerships to expand its reach and accelerate development. Its specialization in upregulating protein expression positions it competitively within the rare disease treatment landscape. Continue reading